Tandem Diabetes Care Inc
TNDM: XNAS (USA)
| Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
|---|---|---|---|
| ^Z? | LOCK|QT | LOCK|h%!z<z |
Tandem Earnings: Few Surprises as the Firm Makes Progress With Mobi Pump
Tandem Diabetes posted second-quarter revenue growth of 6% and approximately halved its negative earnings year over year. Management maintained its outlook, and shares barely bobbled.
